Structure Database (LMSD)

Introduction | Text/ontology-based search | Structure-based search | Programmatic Access

LMSD: Lipid classification search results

Prenol Lipids [PR] (W) --> Quinones and hydroquinones [PR02]
LM_IDCommon NameSystematic NameFormulaMass
LMPR02010001Coenzyme Q10 (W)-C59H90O4862.6839
LMPR02010002Coenzyme Q6-C39H58O4590.4335
LMPR02010003Coenzyme Q4-C29H42O4454.3083
LMPR02010004Coenzyme Q9-C54H82O4794.6213
LMPR02010005Coenzyme Q8-C49H74O4726.5587
LMPR020100312-decaprenyl-5-hydroxy-6-methoxy-3-
methyl-1,4-benzoquinone
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-
3,7,11,15,19,23,27,31,35,39-
decamethyltetraconta-2,6,10,14,18,22,
26,30,34,38-decaen-1-yl]-5-hydroxy-6-
methoxy-3-methylcyclohexa-2,5-diene-1,
4-dione
C58H88O4848.6683
LMPR020100322-decaprenyl-6-methoxy-3-methyl-1,4-
benzoquinone
3-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-
3,7,11,15,19,23,27,31,35,39-
decamethyltetraconta-2,6,10,14,18,22,
26,30,34,38-decaen-1-yl]-5-methoxy-2-
methylcyclohexa-2,5-diene-1,4-dione
C58H88O3832.6733
LMPR020100332-decaprenyl-6-methoxy-1,4-benzoquinone-C57H86O3818.6577
LMPR020100343-decaprenyl-4,5-dihydroxybenzoic acid3-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-
3,7,11,15,19,23,27,31,35,39-
decamethyltetraconta-2,6,10,14,18,22,
26,30,34,38-decaen-1-yl]-4,5-
dihydroxybenzoic acid
C57H86O4834.6526
LMPR020100353-decaprenyl-4-hydroxy-5-
methoxybenzoic acid
3-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-
3,7,11,15,19,23,27,31,35,39-
decamethyltetraconta-2,6,10,14,18,22,
26,30,34,38-decaen-1-yl]-4-hydroxy-5-
methoxybenzoic acid
C58H88O4848.6683
LMPR020100363-demethylubiquinone-92-hydroxy-3-methoxy-6-methyl-5-[(2E,6E,
10E,14E,18E,22E,26E,30E)-3,7,11,15,19,
23,27,31,35-nonamethylhexatriaconta-2,
6,10,14,18,22,26,30,34-nonaen-1-
yl]cyclohexa-2,5-diene-1,4-dione
C53H80O4780.6057
LMPR02010037Plastoquinol-12,3-dimethyl-5-(3-methylbut-2-enyl)-
benzene-1,4-diol
C13H18O2206.1307
LMPR02010038Sulfated Dihydromenaquinone-9(2E,6E,10E,14E,18E,22E,26E,34E)-2,6,10,
14,18,22,26,30,34-nonamethyl-36-(3-
methyl-1,4-dioxo-1,4-dihydronaphthalen-
2-yl)hexatriaconta-2,6,10,14,18,22,26,
34-octaenyl hydrogen sulfate
C56H82O6S882.5832
LMPR02010039Dihydromenaquinone-82-methyl-3-((2E,10E,14E,18E,22E,26E)-3,
7,11,15,19,23,27,31-
octamethyldotriaconta-2,10,14,18,22,26,
30-heptaenyl)naphthalene-1,4-dione
C51H74O2718.5689
LMPR02010040Dihydromenaquinone-92-methyl-3-((2E,10E,14E,18E,22E,26E,
30E)-3,7,11,15,19,23,27,31,35-
nonamethylhexatriaconta-2,10,14,18,22,
26,30,34-octaenyl)naphthalene-1,4-dione
C56H82O2786.6315
LMPR02010041Menaquinone-92-methyl-3-((2E,6E,10E,14E,18E,22E,26E,
30E)-3,7,11,15,19,23,27,31,35-
nonamethylhexatriaconta-2,6,10,14,18,
22,26,30,34-nonaenyl)naphthalene-1,4-
dione
C56H80O2784.6158
LMPR02010042-2-hexaprenyl-6-methoxyphenolC37H56O2532.4280
LMPR02010043 3-Hexaprenyl-4,5-dihydroxybenzoic acidC37H54O4562.4022
LMPR02010044-3-Hexaprenyl-4-hydroxy-5-
methoxybenzoic acid
C38H56O4576.4179
LMPR02010045-3-Hexaprenyl-4-hydroxybenzoic acidC37H54O3546.4073
LMPR02020001α-tocopherol (W)(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,
8,12-trimethyltridecyl]-3,4-dihydro-2H-
chromen-6-ol
C29H50O2430.3811
LMPR02020053γ-CEHC Glcγ-carboxyethyl-hydroxychroman β-D-
glucoside
C21H30O9426.1890
LMPR02020054α-tocotrienol2R,5,7,8-tetramethyl-2-[(3E,7E)-4,8,12-
trimethyltrideca-3,7,11-trien-1-yl]-3,
4-dihydro-2H-chromen-6-ol
C29H44O2424.3341
LMPR02020055β-tocotrienol2R,5,8-trimethyl-2-[(3E,7E)-4,8,12-
trimethyltrideca-3,7,11-trien-1-yl]-3,
4-dihydro-2H-chromen-6-ol
C28H42O2410.3185
LMPR02020056δ-tocotrienol2R,8-dimethyl-2-[(3E,7E)-4,8,12-
trimethyltrideca-3,7,11-trien-1-yl]-3,
4-dihydro-2H-chromen-6-ol
C27H40O2396.3028
LMPR02020057γ-tocotrienol2R,7,8-trimethyl-2-[(3E,7E)-4,8,12-
trimethyltrideca-3,7,11-trien-1-yl]-3,
4-dihydro-2H-chromen-6-ol
C28H42O2410.3185
LMPR02020058didesmethyl tocotrienol2R-[(3E,7E)-4,8,12-trimethyltrideca-3,
7,11-trien-1-yl]-3,4-dihydro-2H-
chromen-6-ol
C25H36O2368.2715
LMPR02020059β-Tocopherol skeleton---
LMPR02020062alhpa-tocopheronic acid-C16H24O5296.1624
LMPR02020063alhpa-tocopheronolactone-C16H22O4278.1518
LMPR02020065γ-tocopherol(2R)-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-
trimethyltridecyl]-3,4-dihydro-2H-
chromen-6-ol
C28H48O2416.3654
LMPR02020066δ-tocopherol(2R)-2,8-dimethyl-2-[(4R,8R)-4,8,12-
trimethyltridecyl]-3,4-dihydro-2H-
chromen-6-ol
C27H46O2402.3498
LMPR02030001Vitamin K2 (W)-C41H56O2580.4280
LMPR020300272-demethylmenaquinone-82-[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,
15,19,23,27,31-octamethyldotriaconta-2,
6,10,14,18,22,26,30-octaen-1-
yl]naphthalene-1,4-dione
C50H70O2702.5376
LMPR02030028phylloquinone (W)2-methyl-3-[(2E,7R,11R)-3,7,11,15-
tetramethylhexadec-2-en-1-
yl]naphthalene-1,4-dione
C31H46O2450.3498
LMPR020300293-hydroxy-2-methyl-3-phytyl-2,3-
dihydro-1,4-naphthoquinone
2-hydroxy-3-methyl-2-[(2E,7R,11R)-3,7,
11,15-tetramethylhexadec-2-en-1-yl]-2,
3-dihydro-1,4-naphthoquinone
C31H48O3468.3603
LMPR02030030phyllohydroquinone2-methyl-3-[(2E,7R,11R)-3,7,11,15-
tetramethylhexadec-2-en-1-
yl]naphthalene-1,4-diol
C31H48O2452.3654
LMPR020300312,3-epoxyphylloquinone7a-methyl-1a-[(2E,7R,11R)-3,7,11,15-
tetramethylhexadec-2-en-1-yl]-1a,7a-
dihydronaphtho[2,3-b]oxirene-2,7-dione
C31H46O3466.3447
 

logo LIPID MAPS is funded by a Wellcome Trust.